The exemption will benefit Anti-Retroviral Drugs (ARV Drugs) -- Adult First Line, Adult Second Line and Paediatric Drugs.

Strides Arcolab said US health regulator has approved its drug used for treating HIV infection in adult and children for sale in US market.

Lupin launched the generic version of ViiV Healthcare's Trizivir tablets in the US market with 180-days of marketing exclusivity.

The company's product is indicated in combination with other antiretrovirals or alone for the treatment of HIV-1 infection, it added.

Here is a list of twelve stocks that are likely to be in action in morning trade today.

Drug firms Lupin Ltd and Aurobindo Pharma today said they have received approval to sell generic Combivir tablets, used in treating HIV inf...

Drug firm Strides Arcolab today said it has received tentative approval from US health regulator for fixed dose combination of Lamivudine a...

US government will not source drugs under its global AIDS drug supply programme from Ranbaxy plants in India. Top food myths| Successful bi...

The development follows the US Food and Drug Administration’s (USFDA) ban on Ranbaxy’s 30 generic drugs and seven APIs.

According to information available on the USFDA website, the tentative approval is for 150 mg of Lamivedine and 300 mg for Zidovudine.

Blockbuster AIDS drug Viread is set to witness a price war in the domestic market in the next few days, benefitting lakhs of patients using...

Aurobindo Pharma on Monday said it has received a tentative New Drug Approval from USFDA for its fixed dose combination product used for tr...

The USFDA has issued a warning letter to domestic pharma major Ranbaxy for deviations from good manufacturing practices at its Paonta Sahib...

In what could be a belated budget rollback that would benefit both pharma MNCs and the consumer, the government has decided to withdraw the...